Mobileye (MBLY) Reports Q2 2026 Results: Guidance Raised, R&D Incentive Boost, and Strategic Advances
Key Financial Highlights
- Q2 2026 Revenue: \$508 million, virtually unchanged from Q2 2025 (\$506 million). Revenue growth was driven by a 3% increase in system shipment volumes, offset by lower average selling prices (ASP), largely due to higher-than-expected China OEM export volumes.
- Profitability Metrics:
- GAAP Operating Loss: \$(30) million, a 59% improvement from \$(74) million in Q2 2025.
- Adjusted Operating Income (Non-GAAP): \$155 million, up 46% from \$106 million in Q2 2025.
- GAAP Net Loss: \$(21) million, compared to \$(67) million a year ago.
- Adjusted Net Income (Non-GAAP): \$155 million, up 52% from \$102 million in Q2 2025.
- Diluted EPS (GAAP): \$(0.03), versus \$(0.08) in Q2 2025.
- Adjusted Diluted EPS (Non-GAAP): \$0.19, up from \$0.13 a year ago.
- Gross Margin Compression: Gross margin declined to 46% (from 50% in Q2 2025) as a result of a reduction in EyeQ ASPs and higher revenue share from lower-margin SuperVision hardware.
- Operating Cash Flow: \$210 million in the first half of 2026. The company’s liquidity remains robust with \$1.4 billion in cash, cash equivalents, marketable securities, and deposits.
- Share Buyback: \$24 million in share repurchases completed after the program was announced on April 23, 2026.
2026 Full-Year Guidance Raised and Narrowed
- Revenue Guidance: Midpoint increased by \$20 million to a range of \$1,970 – \$2,020 million (previous: \$1,935 – \$2,015 million), implying 4%–7% YoY revenue growth.
- Operating Loss (GAAP): Midpoint reduced by 4%.
- Adjusted Operating Income (Non-GAAP): Midpoint increased by 88% to \$365 – \$425 million (previous: \$185 – \$235 million).
- Main Driver for Guidance Revision: The positive change is primarily attributed to the recognition of a significant R&D incentive grant under the newly enacted Israeli “R&D Law” (Law for the Encouragement and Incentivization of Research and Development 2026), which was applied retroactively from the start of 2026. This grant offsets R&D expenses by approximately \$110 million (GAAP) and \$93 million (Non-GAAP) for Q2, and is expected to provide \$197 – \$217 million (GAAP) or \$180 – \$200 million (Non-GAAP) benefit for the full year 2026. The law allows grants to continue indefinitely and is a direct response to Israel’s implementation of the OECD Pillar Two global minimum tax rules, preserving R&D competitiveness.
- Goodwill Impairment: A non-cash goodwill impairment charge of \$3,788 million was recorded in the first half of 2026, significantly impacting net income (loss) but excluded from adjusted results.
Operational and Strategic Developments
- Commercial Robotaxi Progress: Collaboration with Volkswagen Group’s MOIA continued as planned. Public user testing of Mobileye’s self-driving system equipped vehicles began in Hamburg, Germany (with safety drivers).
- Mobility-as-a-Service Expansion: Mobileye accelerated its efforts in vertically integrated commercial mobility. Engagements with vendors for vehicle platform supply, system installation, and fleet logistics are underway. The company is boosting Moovit’s consumer app, fleet optimization, and rider engagement, positioning itself to scale robotaxi commercialization via MOIA, Holon, and third-party platforms.
- ADAS Momentum and New Program Wins: Strong demand persists for Mobileye’s next-generation, high-volume ADAS platforms, which provide advanced safety and hands-free highway driving at competitive costs. Multiple new Surround ADAS design wins were supplemented by a high-volume Cloud-Enhanced ADAS win with Stellantis, a program with gross profit per unit more than double Mobileye’s base ADAS products.
- Mentee Robotics Acquisition: Mobileye completed the acquisition of Mentee Robotics in 2026, marking an entry into humanoid robotics and the future of physical AI.
Additional Financial Details
- Balance Sheet (as of June 27, 2026):
- Total assets: \$8.84 billion (down from \$12.49 billion at December 27, 2025, mostly due to the goodwill impairment).
- Total equity: \$8.21 billion.
- Total liabilities: \$628 million.
- Cash Flow:
- Net cash provided by operating activities (H1 2026): \$210 million.
- Net cash used in investing activities: \$(719) million, primarily due to \$591 million for the Mentee Robotics acquisition.
- Supplemental Data:
- Q2 2026 system shipments: 10.0 million units (up from 9.7 million in Q2 2025).
- Average EyeQ/SuperVision system price: \$48.5, slightly down from \$49.7 in Q2 2025.
What Investors and Shareholders Need to Know
- R&D Law Incentive: The recognition of a substantial R&D incentive grant is a direct, material driver of the sharp improvement in adjusted operating income and the narrowing of GAAP losses for 2026. This new government-backed support could set a structurally higher margin baseline for Mobileye in future years, which is a significant positive for long-term profitability and valuation.
- Goodwill Impairment: The \$3.8 billion non-cash goodwill impairment is a notable negative headline, but is excluded from non-GAAP performance metrics and does not impact cash flow. However, it signals a revaluation of acquired assets, which could be viewed negatively by some investors.
- Commercialization and Growth Catalysts: Continued momentum in robotaxi deployment, new mobility solutions, and high-margin ADAS program wins (especially with Stellantis) are fundamental drivers that could materially impact Mobileye’s revenue and profit trajectory.
- Guidance Upgrade: The increase in the midpoint of full-year revenue and especially adjusted operating income guidance is price-sensitive and likely to be viewed positively by the market. The company’s confidence in 2026 and beyond is underpinned by multiple business and regulatory tailwinds.
- Share Buyback: The initiation of a share repurchase program and actual repurchases in Q2 signal management’s confidence in the value of the business and could support the share price.
Conclusion
Mobileye’s Q2 2026 report delivers a mix of robust operational performance, a substantial boost from the new Israeli R&D Law, and continued progress in next-generation mobility and ADAS solutions. The upward revision to 2026 guidance, the structural cost support from government incentives, and new program wins all represent material, potentially price-moving developments. The goodwill impairment, while a large GAAP headline charge, is non-cash and does not detract from the company’s underlying operational strength and growth prospects.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should consult official filings and their financial advisors before making any investment decisions. Past performance is not indicative of future results. All forward-looking statements are subject to risks and uncertainties as detailed in Mobileye’s public filings.
